Core Laboratories NV

Find Ratings Reports
CLB : NYSE : Basic Materials
$112.33 up 1.85 | 1.67%
Today's Range: 109.98 - 113.23
Avg. Daily Volume: 488,300
09/30/16 - 4:02 PM ET

Financial Analysis


CORE LABORATORIES NV's gross profit margin for the second quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Sales and net income fell significantly; although net income growth outperformed the average competitor in its industry, revenue growth did not. CORE LABORATORIES NV has average liquidity. Currently, the Quick Ratio is 1.43 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.

At the same time, stockholders' equity ("net worth") has greatly increased by 14,338.09% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY16 Q2 FY15
Net Sales ($mil)148.07203.89
EBITDA ($mil)26.9356.64
EBIT ($mil)20.1849.71
Net Income ($mil)16.6234.63


Balance Sheet Q2 FY16 Q2 FY15
Cash & Equiv. ($mil)14.7822.58
Total Assets ($mil)572.11658.99
Total Debt ($mil)208.8421.62
Equity ($mil)161.851.12


Profitability Q2 FY16 Q2 FY15
Gross Profit Margin25.7133.97
EBITDA Margin18.1827.77
Operating Margin13.6324.38
Sales Turnover1.191.48
Return on Assets14.0730.15
Return on Equity49.7517726.31
Debt Q2 FY16 Q2 FY15
Current Ratio2.031.95
Debt/Capital0.561.0
Interest Expense3.023.12
Interest Coverage6.6815.95


Share Data Q2 FY16 Q2 FY15
Shares outstanding (mil)44.142.66
Div / share0.550.55
EPS0.380.81
Book value / share3.670.03
Institutional Own % n/a n/a
Avg Daily Volume460975.0542837.0

Valuation


HOLD. CORE LABORATORIES NV's P/E ratio indicates a significant premium compared to an average of 27.49 for the Energy Equipment & Services industry and a significant premium compared to the S&P 500 average of 25.19. For additional comparison, its price-to-book ratio of 29.37 indicates a significant premium versus the S&P 500 average of 2.82 and a significant premium versus the industry average of 2.65. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, CORE LABORATORIES NV proves to trade at a premium to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
CLB 57.65 Peers 27.49   CLB 27.76 Peers 11.99

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

CLB is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

CLB is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
CLB 47.08 Peers 120.26   CLB NM Peers 0.24

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

CLB is trading at a significant discount to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

CLB's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
CLB 29.37 Peers 2.65   CLB -58.82 Peers -338.13

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

CLB is trading at a significant premium to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

CLB is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
CLB 6.97 Peers 2.61   CLB -29.89 Peers -35.95

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

CLB is trading at a significant premium to its industry.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

CLB significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades